The document is an intimation regarding the availability of audio recording for the company's Earnings Call held on May 28, 2026.
The earnings call discussed the company's operational and financial performance for the quarter and year ended March 31, 2026 (Q4 FY26).
The audio recording has been made available on the company's website at: https://www.supriyalifescience.com/ir-financial.php
The disclosure was signed by Prachi Suhas Sathe, Company Secretary & Compliance Officer, and filed with both BSE Limited and National Stock Exchange of India Limited.
Additional Notes Section
This is a follow-up communication to previous letters dated May 23, 2026 and May 27, 2026.
No financial data or specific performance figures were disclosed in this announcement.
The document contains standard company contact information including corporate office and factory addresses.